More than 230 organizations representing healthcare providers, public health professionals, and others have sent a letter to Congress urging for steps to address antimicrobial resistance.
The early days of the COVID-19 pandemic sparked widespread alarm as to how infectious diseases spread. For most of us, COVID-19 was the first pandemic we lived through. Never had
The PASTEUR Act, as amended, would provide $6 billion in federal funding over several years to give drugmakers incentive to develop and manufacture lifesaving medications for the small but growing number of infections highly resistant to antibiotics.
With time running out in the 2022 congressional session, a bipartisan coalition of lawmakers and infectious disease specialists is scrambling to pass a bill aimed at spurring the development of antibiotics to combat the deadly spread of drug-resistant pathogens.